Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.46
-0.28 (-1.58%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,521,591
Open
17.73
Bid (Size)
17.46 (4)
Ask (Size)
17.49 (2)
Prev. Close
17.74
Today's Range
17.41 - 17.74
52wk Range
8.055 - 19.08
Shares Outstanding
1,110,352,397
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Performance
YTD
+63.64%
+63.64%
1 Month
-5.93%
-5.93%
3 Month
+7.45%
+7.45%
6 Month
+25.52%
+25.52%
1 Year
+70.84%
+70.84%
More News
Read More
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today
September 16, 2024
Via
Benzinga
Key Takeaways From Teva Pharmaceutical Indus Analyst Ratings
September 03, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
August 21, 2024
Via
Benzinga
Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia
September 23, 2024
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
September 21, 2024
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
September 21, 2024
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
Teva to Present at the Bank of America 2024 Global Healthcare Conference
September 11, 2024
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
Via
Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
September 10, 2024
Via
Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
September 06, 2024
Via
Benzinga
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
September 06, 2024
Via
Benzinga
Organon Stock Sees Relative Strength Rating Rise To 91
August 27, 2024
Via
Investor's Business Daily
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
From
Teva Pharmaceutical Industries Ltd
Via
GlobeNewswire
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Via
Benzinga
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
Via
Investor's Business Daily
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
August 13, 2024
Via
Benzinga
The 7 Best Under $20 Stocks to Buy in August 2024
August 07, 2024
Via
InvestorPlace
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
Via
PressReach
Exposures
Product Safety
What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.
August 02, 2024
Via
InvestorPlace
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
July 31, 2024
Via
Benzinga
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript
July 31, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales
July 31, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.